Babaodan alleviates MAFLD through hepatic glycerophospholipid metabolism and PPARγ/RXRA/GPAT3 based on spatial metabolomics and proteomics analysis
Fields of Study & Subjects
Liver Disease Diagnosis and Treatment
Lipid metabolism and disorders
Peroxisome Proliferator-Activated Receptors
Publication details
- Journal / source
- Journal of Ethnopharmacology
- Publisher
- Elsevier BV
- Volume
- 364
- Pages
- 121475–121475
- Publication date
- 4 March 2026
- Language
- EN